Trials / Enrolling By Invitation
Enrolling By InvitationNCT03687710
The Comparative Effectiveness Dementia & Alzheimer's Registry
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 452 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effectiveness of using clinical precision medicine to develop lifecourse interventions for Alzheimer's disease (AD) prevention and treatment. Anthropometrics, blood biomarkers (including genetics), and cognition will measured longitudinally to assess the comparative effectiveness of clinical care.
Detailed description
The Comparative Effectiveness Dementia \& Alzheimer's Registry (CEDAR) Project is a prospective, observational registry of adult patients at-risk for, or with, a diagnosis of dementia due to Alzheimer's disease (AD) or other neurodegenerative dementias. The purpose of this study is to develop a research repository, or database, for information collected during routine medical care of people with normal memory and family history of AD, or with memory loss or other changes in thinking. The registry will help generate empirical evidence that improves knowledge and informs care decisions about risk reduction for dementia due to AD, and about the effectiveness of a clinical precision medicine intervention. Using a life course approach to comparative effectiveness research will enable investigators to analyze the effects of evidence-based multidomain interventions on cognition, biomarkers of AD risk, and calculated AD risk across the pre-dementia spectrum of AD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Multidomain precision medicine intervention | Participants will receive individualized evidence-based multidomain interventions (education, pharmacologic, non-pharmacologic) in the setting of routine outpatient clinical care. |
Timeline
- Start date
- 2015-02-16
- Primary completion
- 2028-06-30
- Completion
- 2028-06-30
- First posted
- 2018-09-27
- Last updated
- 2026-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03687710. Inclusion in this directory is not an endorsement.